257 related articles for article (PubMed ID: 29875257)
1. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.
den Hollander WJ; Holster IL; den Hoed CM; Capelle LG; Tang TJ; Anten MP; Prytz-Berset I; Witteman EM; Ter Borg F; Hartog GD; Bruno MJ; Peppelenbosch MP; Lesterhuis W; Doukas M; Kuipers EJ; Spaander MCW
Gut; 2019 Apr; 68(4):585-593. PubMed ID: 29875257
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
[TBL] [Abstract][Full Text] [Related]
4. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region.
Esposito G; Dilaghi E; Cazzato M; Pilozzi E; Conti L; Carabotti M; Di Giulio E; Annibale B; Lahner E
Dig Liver Dis; 2021 Apr; 53(4):467-473. PubMed ID: 33199230
[TBL] [Abstract][Full Text] [Related]
7. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
8. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.
Varis K; Sipponen P; Laxén F; Samloff IM; Huttunen JK; Taylor PR; Heinonen OP; Albanes D; Sande N; Virtamo J; Härkönen M
Scand J Gastroenterol; 2000 Sep; 35(9):950-6. PubMed ID: 11063155
[TBL] [Abstract][Full Text] [Related]
9. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
[TBL] [Abstract][Full Text] [Related]
10. Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma.
Na HK; Cho CJ; Bae SE; Lee JH; Park YS; Ahn JY; Kim DH; Choi KD; Song HJ; Lee GH; Jang SJ; Jung HY
PLoS One; 2017; 12(1):e0169456. PubMed ID: 28072871
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up.
Zhang L; Liu Y; You P; Feng G
Scand J Gastroenterol; 2018; 53(7):843-848. PubMed ID: 29911441
[TBL] [Abstract][Full Text] [Related]
12. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).
Lee JWJ; Zhu F; Srivastava S; Tsao SK; Khor C; Ho KY; Fock KM; Lim WC; Ang TL; Chow WC; So JBY; Koh CJ; Chua SJ; Wong ASY; Rao J; Lim LG; Ling KL; Chia CK; Ooi CJ; Rajnakova A; Yap WM; Salto-Tellez M; Ho B; Soong R; Chia KS; Teo YY; Teh M; Yeoh KG
Gut; 2022 May; 71(5):854-863. PubMed ID: 33975867
[TBL] [Abstract][Full Text] [Related]
13. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
14. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
15. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of group D patients with negative serum anti-Helicobacter pylori antibody and positive serum pepsinogen test in healthy Koreans.
Han YM; Chung SJ; Choi JM; Lee C; Kim JS
J Dig Dis; 2018 Sep; 19(9):529-539. PubMed ID: 30117281
[TBL] [Abstract][Full Text] [Related]
18. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
19. Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country.
Lahner E; Hassan C; Esposito G; Carabotti M; Zullo A; Dinis-Ribeiro M; Annibale B
Dig Liver Dis; 2017 Mar; 49(3):291-296. PubMed ID: 28034664
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
